Prevalence of Epilepsy and the Demographics, Clinical and Paraclinical Features in Patients with Multiple Sclerosis (P3.360)

Conclusions:Prevalence of epileptic seizure is increased in our MS database similar to other reports. About half of our patients had first onset seizure when in progressive disease stage and without an identifiable new MS plaques which suggest possible network failure or subclinical grey matter lesions as mechanisms of epileptic activity.Disclosure: Dr. Baharnoori has nothing to disclose. Dr. Stankiewicz has received personal compensation for activities with Teva Neuroscience, Novartis, Sanofi Genzyme, Biogen Idec, Genentech, and Bayer as a consultant. Dr. Chitnis received personal compensation for activities with Roche-Genentech and Sanofi-Genzyme. Dr. Chitnis received research support from EMD Serono, Biogen, Novartis and Verily.
Source: Neurology - Category: Neurology Authors: Tags: Quality of Life, Symptoms and Symptomatic Therapy, Comorbidity, and Patient Reported Outcomes in Multiple Sclerosis Source Type: research